Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025
Autoimmune Encephalitis Misdiagnosis in Adults
JAMA Neurol 80:30-39, Flanagan,E.P.,et al, 2023
Incidental Findings from 16,400 Brain MRI Examinations of Research Volunteers
AJNR 44:417-423, Rowley,P.A.,et al, 2023
Functional Neurological Disorder
Stroke 51:1629-1635, Popkirov, S., et al, 2020
Bornavirus Encephalitis Shows a Characteristic Magnetic Resonance Phenotype in Humans
Ann Neurol 88:723-735, Finck, T.,et al, 2020
MR Imaging of the Brain in Neurologic Wilson Disease
AJNR 40:178-183, Yu, X.-E.,et al, 2019
Diagnosing Stroke in Acute Dizziness and Vertigo
Stroke 49:788-795, Saber Tehrani, A.S.,et al, 2018
Intravenous Thrombolysis in Unwitnessed Stroke Onset: MR WITNESS Trial Results
Ann Neurol 83:980-993, Schwamm, L.H.,et al, 2018
Optimal Timing of Diffusion-Weighted Imaging to Avoid False-Negative Findings in Patients with Transient Ischemic Attack
Stroke 48:1990-1992, Shono, K.,et al, 2017
Diagnosis of DWI-Negative Acute Ischemic Stroke
Neurol 89:256-262, Edlow, B.L.,et al, 2017
The Contemporary Spectrum of Multiple Sclerosis Misdiagnosis
Neurol 87:1393-1399, Solomon, A.J.,et al, 2016
Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016
Spectrum of Imaging Appearances of Intracranial Cryptococcal Infection in HIV/AIDS Patients in the Anti-Retroviral Therapy Era
Clin Radiol 71:9-17, Offiah, C.E. & Naseer, A., 2016
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015
Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014
Clinical Associations and Causes of Convexity Subarachnoid Hemorrhage
Stroke 45:1151-1153, Khurram, A.,et al, 2014
Neuroimaging in Patients with Abnormal Blood Glucose Levels
AJNR 35:833-840, Bathla, G.,et al, 2014
Small Strokes Causing Severe Vertigo
Neurol 83:169-173, Tehrani, A.S.S.,et al, 2014
Diffusion-Weighted Magnetic Resonance Imaging May Underestimate Acute Ischemic Lesions
Stroke 44:1056-1061, Kawana, H.,et al, 2013
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
NEJM 368:914-923,952, Kidwell, C.S.,et al, 2013
Detection of Peripheral Nerve Pathology
Neurol 80:1634-1640, Zaidman, C.,et al, 2013
Diffusion-Weighted Imaging in Acute Hyperammonemic Encephalopathy
Neurohosp 3:125-130, Rosario, M.,et al, 2013
Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013
Utility of MRI in Spinal Arteriovenous Fistula
Neruol 79:25-30,15, Toossi, S.,et al, 2012
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis
Arch Neurol 69:1259-1269, Radue, E.W.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012
Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011
A Case of Hashimoto Encephalopathy Clinical Manifestation, Imaging, Pathology, Treatment, and Prognosis
The Neurologist 17:141-143, Zhao, W.,et al, 2011
Metastatic spinal cord compression
BMJ 342:d2402, Quraishi, N. & Esler, C., 2011
Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011
Paraneoplastic isolated myelopathy Clinical course and neuroimaging clues
Neurol 76:2089-2095, Flanagan, E.P.,et al, 2011
Treatable Neurological Disorders Misdiagnosed as Creutzfeldt-Jakob Disease
Ann Neurol 70:437-444, Chitravas, N.,et al, 2011
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
NEJM 365:1293-1303, OConnor, P.,et al, 2011
Autoimmune Encephalopathy
Semin Neurol 31:144-157, Flanagan, E.,et al, 2011
Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010
The Expanding Clinical Profile of Anti-AMPA Receptor Encephalitis
Neurol 74:857-859, Graus,F.,et al, 2010
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
NEJM 362:416-426, 456, Giovannoni,G.,et al, 2010
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010
A Case of Neuro-Behcet Disease Mimicking Gliomatosis Cerebri
AJNR 31:E1, Varoglu,A.O., 2010
Safety of tPA in Stroke Mimics and Neuroimaging-Negative Cerebral Ischemia
Neurol 74:1340-1345, 1336, Chernyshev,O.Y., et al, 2010
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Agreement Regarding Diagnosis of Transient Ischemic Attach Fairly Low Among Stroke-Trained Neurologists
Stroke 41:1367-1370, Castle,J., et al, 2010
Diagnostic Yield of Double-Dose Gadobutrol in the Detection of Brain Metastasis: Intraindividual Comparison With Double-Dose Gadopentetate Dimeglumine
AJNR 31:1055-1058, Kim,E.S., et al, 2010
Compressive Myelopathy Mimicking Transverse Myelitis
Neurologist 16:120-122, Kelley, B.,et al, 2010
Oral Fingolimod (FTY720) in Multiple Sclerosis: Two-Year Results of a Phase II Extension Study
Neurol 72:73-79, OConnor,P.,et al, 2009
Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009
Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009